SK Bioscience (Korea) Top Management
302440 Stock | 49,100 150.00 0.31% |
SK Bioscience employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Analysis of SK Bioscience's management performance can provide insight into the company performance.
Hoon Kim Insider CTO Director |
Jinyong Park Insider Head Unit |
302440 |
SK Bioscience Management Team Effectiveness
The company has return on total asset (ROA) of 0.1121 % which means that it generated a profit of $0.1121 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1781 %, meaning that it generated $0.1781 on every $100 dollars invested by stockholders. SK Bioscience's management efficiency ratios could be used to measure how well SK Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.SK Bioscience Workforce Comparison
SK Bioscience Co is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 146. SK Bioscience holds roughly 6.0 in number of employees claiming about 4% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.36 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.47 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.47. SK Bioscience Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. SK Bioscience Price Series Summation is a cross summation of SK Bioscience price series and its benchmark/peer.
SK Bioscience Notable Stakeholders
A SK Bioscience stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as SK Bioscience often face trade-offs trying to please all of them. SK Bioscience's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting SK Bioscience's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Hoon Kim | CTO Director | Profile | |
Jinyong Park | Head Unit | Profile | |
SookMi Hwang | Head Affairs | Profile | |
Harry Kleanthous | Ex Innovation | Profile | |
Sally Choe | Head Affairs | Profile | |
JaeYong Ahn | Pres CEO | Profile |
About SK Bioscience Management Performance
The success or failure of an entity such as SK Bioscience often depends on how effective the management is. SK Bioscience management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of 302440 management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the 302440 management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the presentation of SK Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, SK Bioscience's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of SK Bioscience's management manipulating its earnings.
SK Bioscience Workforce Analysis
Traditionally, organizations such as SK Bioscience use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare SK Bioscience within its industry.SK Bioscience Manpower Efficiency
Return on SK Bioscience Manpower
Revenue Per Employee | 154.8B | |
Revenue Per Executive | 154.8B | |
Net Income Per Employee | 59.2B | |
Net Income Per Executive | 59.2B |
Complementary Tools for 302440 Stock analysis
When running SK Bioscience's price analysis, check to measure SK Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SK Bioscience is operating at the current time. Most of SK Bioscience's value examination focuses on studying past and present price action to predict the probability of SK Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SK Bioscience's price. Additionally, you may evaluate how the addition of SK Bioscience to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |